CoChat

TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer

Open access
Yao, Yinan, Li, Hequan, Chen, Junjun, Xu, Weiyi, Yang, Guangdie, Bao, Zhang, Xia, Dajing, Lu, Guohua, Hu, Shuwen, Zhou, Jianying · 2016 · Oncotarget
Cited by 49

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

// Yinan Yao 1, * , Hequan Li 1, * , Junjun Chen 1 , Weiyi Xu 2 , Guangdie Yang 1 , Zhang Bao 1 , Dajing Xia 3, 4 , Guohua Lu 1 , Shuwen Hu 1 , Jianying Zhou 1 1 Department of Respiratory Diseases, First Affiliated Hospital of Zhejiang University, Hangzhou, China 2 Department of Clinical Laboratory, First Affiliated Hospital of Zhejiang University, Hangzhou, China 3 School of Public Health, Zhejiang University, Institute of Immunology, Zhejiang University, Hangzhou, China 4 Institute of Immunology, Zhejiang University, Hangzhou, China * These authors have contributed equally to this work Correspondence to: Jianying Zhou, email: zjyhz@zju.edu.cn Hequan Li, email: lihequan@zju.edu.cn Keywords: TREM-2, lung cancer, IL-10, Syk, immunoregulation Received: October 20, 2015 Accepted: March 28, 2016 Published: April 18, 2016 ABSTRACT During infection, triggering receptor expressed on myeloid cells-2 (TREM-2) restrains dendritic cells (DCs) and macrophages (MΦs) phagocytosis, as well as reduces pro-inflammatory cytokines release through DNAX-activation protein 12 (DAP12) signaling. However, the role of TREM-2 signaling in cancer has never been elucidated. In the current study, we found that TREM-2 was up-regulated on peripheral blood monocytes in tumor-bearing host. More TREM-2 + DCs were detected in the lung of 3LL tumor-bearing mice. On the other hand, the level of TREM-2 on pulmonary MΦs positively correlated with the pathological staging of lung cancer. However, surgical or chemotherapeutic reduction of tumor burden led to the obvious decline of TREM-2. In vitro, TREM-2 expression of bone marrow (BM)-derived DCs and MΦs was induced by conditional medium (CM) containing the supernatant of 3LL cells. TREM-2 + DCs from CM and/or tumor-bearing mice held altered phenotypes (CD80 Low CD86 Low MHCII Low ) and impaired functions, such as, reduced interleukin (IL)-12 secretion, increased IL-10 production, and weakened ovalbumin (OVA)-endocytic capacity; also developed potent inhibitory effect on T cell proliferation that could be partially reversed by TREM-2 blockage. Moreover, spleen tyrosine kinase (Syk) inhibitor restrained IL-10 production of TREM-2 + DC. Remarkably, IL-10 neutralizing antibody and Syk inhibitor both lowered the suppressive potential of TREM-2 + DCs in T cell proliferation. Also, adoptive transfer of this TREM-2 + DCs accelerated the tumor growth rather than jeopardized survival in lung cancer-bearing mice. In conclusion, these results indicate that TREM-2 might act as a negative immuno-regulatory molecule through Syk pathway in an IL-10 dependent manner and partially predicts prognosis in lung cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.8813

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 49

Metadata

Authors
Yao, Y., Li, H., Chen, J., Xu, W., Yang, G., Bao, Z., Xia, D., Lu, G., Hu, S., & Zhou, J.
Venue
Oncotarget
Published
2016-04-18
Volume
7
Issue
20
Pages
29620-29634
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2338711703
Cited by
49
References
12
FWCI
0.67
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer. https://app.cochat.ai/papers/10.18632/oncotarget.8813
The paper
Yao, Y., Li, H., Chen, J., Xu, W., Yang, G., Bao, Z., Xia, D., Lu, G., Hu, S., & Zhou, J. (2016). TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer. Oncotarget. https://doi.org/10.18632/oncotarget.8813

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.